Crawford Investment Counsel Inc. Invests $791,000 in Ralliant Corporation $RAL

Crawford Investment Counsel Inc. acquired a new position in shares of Ralliant Corporation (NYSE:RAL) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 18,080 shares of the company’s stock, valued at approximately $791,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Dodge & Cox bought a new position in Ralliant during the second quarter worth about $523,571,000. Viking Global Investors LP bought a new stake in shares of Ralliant in the 2nd quarter valued at about $257,200,000. State Street Corp acquired a new stake in shares of Ralliant in the 2nd quarter valued at approximately $213,096,000. Norges Bank acquired a new stake in shares of Ralliant in the 2nd quarter valued at approximately $108,453,000. Finally, Invesco Ltd. bought a new position in Ralliant during the 2nd quarter worth approximately $98,753,000.

Ralliant Price Performance

Shares of RAL opened at $42.34 on Monday. The stock has a 50 day simple moving average of $48.24 and a 200 day simple moving average of $46.76. Ralliant Corporation has a 52-week low of $37.27 and a 52-week high of $57.02. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84. The firm has a market capitalization of $4.73 billion and a PE ratio of 21.60.

Ralliant (NYSE:RAL) last announced its earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. The business’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio (DPR) is presently 10.20%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on RAL shares. Weiss Ratings cut shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Royal Bank Of Canada reduced their price target on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a research report on Friday, February 6th. Zacks Research lowered shares of Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a research report on Friday, February 6th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $45.00 price objective on shares of Ralliant in a research note on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $50.50.

Insiders Place Their Bets

In other Ralliant news, SVP Karen M. Bick sold 2,530 shares of Ralliant stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $46.50, for a total value of $117,645.00. Following the sale, the senior vice president owned 42,652 shares of the company’s stock, valued at $1,983,318. This trade represents a 5.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Kevin E. Bryant purchased 1,250 shares of the company’s stock in a transaction on Friday, February 6th. The stock was purchased at an average cost of $39.97 per share, for a total transaction of $49,962.50. Following the purchase, the director directly owned 4,653 shares in the company, valued at approximately $185,980.41. This trade represents a 36.73% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 8,145 shares of company stock worth $332,233 in the last ninety days.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.